FH cascade screening more efficient than universal tests
5th March 2013
By Niamh Mullen
Associate Professor David Sullivan, from the department of clinical biochemistry at the Royal Prince Alfred Hospital, Sydney, said the cost-effectiveness evidence for cascade screening was convincing, but only Western Australia had a government-funded program.
“Holland is the glowing example,” Professor Sullivan told the Pathology Update conference.
“They detect 70% of people with the problem. In the next generation they will have